Latest Lead News

Cann Group Limited has successfully raised an additional $2.5 million through a Share Purchase Plan and shortfall placement, complementing a prior $6.5 million institutional placement. These funds will primarily support debt repayment and strengthen the company’s financial position.

HeraMED has achieved a significant regulatory milestone with the Therapeutic Goods Administration upgrading its HeraBEAT fetal heart rate monitor to Class IIb, making it the only remote home-use device approved in Australia. This positions the company for a potentially lucrative expansion in the Australian maternity care market.

Cazaly Resources has raised $3.5 million through a strongly supported placement to accelerate reverse circulation drilling at its Goongarrie Gold Project in Western Australia. The capital injection positions the company to expand exploration efforts and advance key targets in a promising gold region.

Evolution Energy Minerals is set to launch an extensive soil sampling program at its Chikundo Copper Project in Tanzania, aiming to refine targets ahead of 2026 drilling. The initiative builds on strong historical and recent copper assay results within a promising volcanic caldera setting.

Island Pharmaceuticals has engaged a top Washington DC government affairs firm to accelerate its US biodefence strategy, focusing on its antiviral drug Galidesivir amid promising FDA regulatory signals.

Ava Risk Group announces the upcoming retirement of CEO Mal Maginnis, with senior executive Neville Joyce appointed as Acting CEO. The company embarks on a global search for a permanent replacement amid strong recent growth.

Orthocell Limited reports growing adoption of its Remplir™ nerve repair product in nerve-sparing prostate cancer surgeries across Australia, positioning for a significant U.S. market expansion. The company is investing in research and commercial infrastructure ahead of a medium-term U.S. launch.

Sonic Healthcare has reaffirmed its FY2026 EBITDA guidance with up to 13% growth, reported solid FY2025 financial results, and announced a strategic acquisition in Germany alongside notable sustainability progress.

CVC Limited has released a replacement prospectus for its $75 million CVC Notes 3 offer, combining a New Money Offer and a Reinvestment Offer for existing CVCHA holders. The notes aim to support CVC’s capital management and real estate investment strategy.

Dataworks Limited solidifies its leadership in regulated gaming technology with its Centralised Self-Exclusion platform, backed by major government contracts and a robust growth pipeline.

Orion Minerals is on the cusp of finalising a significant financing and offtake agreement with Glencore, potentially unlocking up to US$250 million for its Prieska Copper Zinc Mine.

Apiam Animal Health reported a challenging FY25 with underperformance in its core clinical segment but has rebounded strongly in Q1 FY26. The company is now poised for acquisition by Adamantem Capital, offering shareholders a premium cash and scrip deal.